CHINATRIALS 2011 Advisory Board
 James Cai, Ph.D. Vice President, Clinical Development ATYR PHARMA |
 James Garner, M.D. Vice President & General Manager TAKEDA GLOBAL R&D CENTER ASIA |
 Min Irwin, M.D., Ph.D. Medical Director of BSP BAYER HEALTHCARE |
 |
||
 Frank Jiang, M.D., Ph.D. Vice President, Global R&D/Head, China R&D SANOFI-AVENTIS |
 Simon Li, M.D., Ph.D Global Clinical Leader, PC BAYER HEALTHCARE |
 Qing Li, M.D., Ph.D. Senior Director, OTC R&D XIAN-JANSSEN PHARMACEUTICAL |
|
||
 Bradley Marchant, M.D. Senior Director, Unit Development Office, Asia Pacific R&D SANOFI-AVENTIS |
 Fidela Moreno, M.D. Vice President, Global Development Operations - Clinical Monitoring ALLERGAN |
 Bin Peng, M.D., Ph.D. Senior Director, Clinical Program Leader/Head of Oncology Translation Medicine, China NOVARTIS |
|
||
 Sally Sha Business Development Director & Project Director TIGERMED |
 Yan Yan Starkey, M.D., MBA Director of R&D, China/Global R&D GSK CONSUMER HEALTHCARE |
 Claire Tan Senior Director, Biostatistics QUINTILES |
|
||
 Jingsong Wang, M.D. Director Discovery Medicine & Clinical Pharmacology BRISTOL-MYERS SQUIBB |
 William Wang, Ph.D. Head, Asia Pacific Operations, BARDS MERCK & CO. |
 Songlin Xue, M.D., Ph.D Senior Vice President & Global Head of Pharmacovigilance TAKEDA PHARMACEUTICALS |
|
||
 Li Yan, M.D., Ph.D. Head of Clinical Development, Infectious Disease, Immunology & Oncology; Emerging Markets MERCK & CO. |
 Dan Zhang Chief Executive Officer FOUNTAIN MEDICAL DEVELOPMENT |
|
|
||
 |
|
|
 |
About Your Organizer Jon E. Liong, Managing Partner, LYCHEE GROUP |